Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia

This study has been terminated.
Hoffmann-La Roche
Shekhar, Anantha M.D., Ph.D.
Information provided by (Responsible Party):
Indiana University ( Indiana University School of Medicine ) Identifier:
First received: September 19, 2005
Last updated: March 25, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2008
  Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)